On September 23, 2026, IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings Inc., completed the issuance and sale of $2 billion in gross proceeds from 6.375% senior notes due March 15, 2034. The net proceeds will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, repay a portion of outstanding indebtedness under the revolving credit facility, and pay related fees and expenses. Interest on the new notes is payable semi-annually on March 15 and September 15, beginning March 15, 2027. The company operates in the healthcare information technology and clinical research services industry.
